Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli

Molecular Microbiology

Volumn 44, Issue 4, 2002, Pages 957-970

  Wagner, Patrick L ^a,b   Livny, Jonathan ^c   Neely, Melody N ^c,d   Acheson, David W K ^b,e   Friedman, David I ^c   Waldor, Matthew K ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; IRON REGULATORY FACTOR; PROTEIN PSTX1; SHIGA TOXIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIOPHAGE LAMBDA; CONTROLLED STUDY; ENVIRONMENT; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE CONTROL; GENE REPLICATION; GENETIC TRANSCRIPTION; LYSIS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; VIROGENESIS; VIRUS GENOME; VIRUS INDUCTION;

BACTERIOPHAGE LAMBDA; ESCHERICHIA COLI; GENE DOSAGE; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; GENOME, VIRAL; IRON; MITOMYCIN; PROMOTER REGIONS (GENETICS); PROVIRUSES; RNA, VIRAL; SHIGA-LIKE TOXIN I; TERMINATOR REGIONS (GENETICS); TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRULENCE; VIRUS ACTIVATION; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); BACTERIOPHAGE H-19B; BACTERIOPHAGE LAMBDA; ESCHERICHIA COLI; NEGIBACTERIA; UNIDENTIFIED BACTERIOPHAGE;

EID: 0036096415     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2002.02950.x     Document Type: Article

References (58)

1. Which Shiga-toxin producing types of E. coli are important?
2. High yield purification and subunit characterization of Shiga-like toxin II
3. A method of enhancing verocytotoxin production by Escherichia coli
4. Virulence, toxinogeny and lysogeny in Corynebacterium diphtheriae
5. Risk factors for development of hemolytic uremic syndrome during shigellosis
6. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus
7. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli
8. Evolution of lambdoid phages
9. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home
10. Control of transcription termination: A rho-dependent termination site in bacteriophage lambda
11. Q-mediated late gene transcription of bacteriophage lambda: RNA start point and RNase III processing sitesin vivo
12. How the phage lambda N gene product suppresses transcription termination: Communication of RNA polymerase with regulatory proteins mediated by signals in nascent RNA
13. One-step inactivation of chromosomal genes in Escherichia coli using PCR products
14. Analysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p Shiga-like toxin structural genes
15. Mobile genetic elements and bacterial pathogenesis
16. Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B
17. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive selection suicide vector
18. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies
19. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies
20. Bacteriophage lambda: Alive and well and still doing its thing
21. Lytic mode of lambda development
22. Lambda DNA replication
23. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli
24. Purification and characterization of verocytotoxin 2
25. The origins and ongoing evolution of viruses
26. Site-specific integration of the conjugal Vibrio cholerae SXT element into prfC
27. Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19
28. Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli
29. Comparison of DNA probe and mitomycin C-enhanced immunoblot assay for the detection of Shiga-like toxin producing E. coli in stool specimens
30. Mitomycin immunoblot colony assay for detection of Shiga like toxin-producing Escherichia coli in fecal samples: Comparison with DNA probes
31. Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli
32. Shiga toxins even when different are encoded at identical positions in the genomes of related temperate bacteriophages
33. The primary structure of the operons coding for Shigella dysenteriae toxin and temperate phage H30 Shiga-like toxin
34. The SOS regulatory system
35. Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak
36. Duplication and amplification of toxin genes in Vibrio cholerae
37. The so-called chromosomal verotoxin genes are actually carried by defective prophages
38. Regulation of the Shiga-like toxin II operon in Escherichia coli
39. Arrangement and functional identification of genes in the regulatory region of lambdoid phage H-19B, a carrier of a Shiga-like toxin
40. Functional and genetic analysis of regulatory regions of coliphage H-19B: Location of Shiga-like toxin and lysis genes suggest a role for phage functions in toxin release
41. DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages
42. Lateral gene transfer and the nature of bacterial innovation
43. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observations
44. Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product
45. Control of RNA chain elongation and termination
46. Lysogenic induction
47. Antitermination by bacteriophage lambda Q protein
48. Plasmid formation: A new mode of lysogeny by phage lambda
49. The transmissible nature of enterotoxin production in a human enteropathogenic strain of Escherichia coli
50. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli
51. Structural analysis of phage-borne stx genes and their flanking sequences in Shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains
52. Isogenic lysogens of diverse Shiga toxin 2-encoding bacteriophages produce markedly different amounts of Shiga toxin
53. Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain
54. Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli
55. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli 0157:H7 infections
56. Phages will out: Strategies of host cell lysis
57. An efficient recombination system for chromosome engineering in Escherichia coli